Skip to main content
Top
Published in: BMC Cancer 1/2023

Open Access 01-12-2023 | Prostate Cancer | Research

Deep learning–based radiomic nomograms for predicting Ki67 expression in prostate cancer

Authors: Shuitang Deng, Jingfeng Ding, Hui Wang, Guoqun Mao, Jing Sun, Jinwen Hu, Xiandi Zhu, Yougen Cheng, Genghuan Ni, Weiqun Ao

Published in: BMC Cancer | Issue 1/2023

Login to get access

Abstract

Background

To explore the value of a multiparametric magnetic resonance imaging (MRI)-based deep learning model for the preoperative prediction of Ki67 expression in prostate cancer (PCa).

Materials

The data of 229 patients with PCa from two centers were retrospectively analyzed and divided into training, internal validation, and external validation sets. Deep learning features were extracted and selected from each patient’s prostate multiparametric MRI (diffusion-weighted imaging, T2-weighted imaging, and contrast-enhanced T1-weighted imaging sequences) data to establish a deep radiomic signature and construct models for the preoperative prediction of Ki67 expression. Independent predictive risk factors were identified and incorporated into a clinical model, and the clinical and deep learning models were combined to obtain a joint model. The predictive performance of multiple deep-learning models was then evaluated.

Results

Seven prediction models were constructed: one clinical model, three deep learning models (the DLRS-Resnet, DLRS-Inception, and DLRS-Densenet models), and three joint models (the Nomogram-Resnet, Nomogram-Inception, and Nomogram-Densenet models). The areas under the curve (AUCs) of the clinical model in the testing, internal validation, and external validation sets were 0.794, 0.711, and 0.75, respectively. The AUCs of the deep models and joint models ranged from 0.939 to 0.993. The DeLong test revealed that the predictive performance of the deep learning models and the joint models was superior to that of the clinical model (p < 0.01). The predictive performance of the DLRS-Resnet model was inferior to that of the Nomogram-Resnet model (p < 0.01), whereas the predictive performance of the remaining deep learning models and joint models did not differ significantly.

Conclusion

The multiple easy-to-use deep learning–based models for predicting Ki67 expression in PCa developed in this study can help physicians obtain more detailed prognostic data before a patient undergoes surgery.
Literature
4.
go back to reference Panebianco V, Villeirs G, Weinreb JC, Turkbey BI, Margolis DJ, Richenberg J, et al. Prostate magnetic resonance imaging for local recurrence reporting (PI-RR): International Consensus -based Guidelines on Multiparametric magnetic resonance imaging for prostate Cancer recurrence after Radiation Therapy and Radical Prostatectomy. Eur Urol Oncol. 2021;4(6):868–76. https://doi.org/10.1016/j.euo.2021.01.003.CrossRefPubMed Panebianco V, Villeirs G, Weinreb JC, Turkbey BI, Margolis DJ, Richenberg J, et al. Prostate magnetic resonance imaging for local recurrence reporting (PI-RR): International Consensus -based Guidelines on Multiparametric magnetic resonance imaging for prostate Cancer recurrence after Radiation Therapy and Radical Prostatectomy. Eur Urol Oncol. 2021;4(6):868–76. https://​doi.​org/​10.​1016/​j.​euo.​2021.​01.​003.CrossRefPubMed
21.
go back to reference Ao W, Cheng G, Lin B, Yang R, Liu X, Zhou S, et al. A novel CT-based radiomic nomogram for predicting the recurrence and metastasis of gastric stromal tumors. Am J Cancer Res. 2021;11(6):3123–34.PubMedPubMedCentral Ao W, Cheng G, Lin B, Yang R, Liu X, Zhou S, et al. A novel CT-based radiomic nomogram for predicting the recurrence and metastasis of gastric stromal tumors. Am J Cancer Res. 2021;11(6):3123–34.PubMedPubMedCentral
35.
go back to reference Hiremath A, Shiradkar R, Fu P, Mahran A, Rastinehad AR, Tewari A, et al. An integrated nomogram combining deep learning, prostate imaging-reporting and data system (PI-RADS) scoring, and clinical variables for identification of clinically significant prostate cancer on biparametric MRI: a retrospective multicentre study. Lancet Digit Health. 2021;3(7):e445–54. https://doi.org/10.1016/S2589-7500(21)00082-0.CrossRefPubMedPubMedCentral Hiremath A, Shiradkar R, Fu P, Mahran A, Rastinehad AR, Tewari A, et al. An integrated nomogram combining deep learning, prostate imaging-reporting and data system (PI-RADS) scoring, and clinical variables for identification of clinically significant prostate cancer on biparametric MRI: a retrospective multicentre study. Lancet Digit Health. 2021;3(7):e445–54. https://​doi.​org/​10.​1016/​S2589-7500(21)00082-0.CrossRefPubMedPubMedCentral
Metadata
Title
Deep learning–based radiomic nomograms for predicting Ki67 expression in prostate cancer
Authors
Shuitang Deng
Jingfeng Ding
Hui Wang
Guoqun Mao
Jing Sun
Jinwen Hu
Xiandi Zhu
Yougen Cheng
Genghuan Ni
Weiqun Ao
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2023
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-11130-8

Other articles of this Issue 1/2023

BMC Cancer 1/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine